Ben Goldacre on Bad Pharma

Ben Goldacre is back with a follow up to his great book Bad Science. It’s called Bad Pharma and I can’t wait to read it.

He recently spoke on the subject at TEDMED. Check it out here:

He talks about the publication bias in favour of positive trials – such that ‘only freaks get published’. Highlighting examples such as reboxetine and oseltamivir (tamiflu) he shows that publication bias is a cancer eating at the heart of evidence-based medicine. Goldacre asks all to call for the mandatory publication of all drug trials ever performed to fix this disastrous situation.

Count me in.

Hat tip to @amcunningham for the link.

Learn more:

Print Friendly

Comments

  1. says

    “…positive finding are 50% more likely to be published than negative findings … publication bias is a ‘systematic flaw in the core of medicine’….it is the ‘cancer at the core of evidence based medicine’….
    What a legendary talk -- well done Ben Goldacre for bring to the forefront this significant issue in academia.

Comments